Join the waitlist
We’re building toward a SaaS platform launch and looking for beta users. Foundations, labs, and biotech R&D teams on the waitlist get first access to evidence assets in the meantime: variant reports, cohort packages, mechanistic diligence. Tell us your use case so we can match you to the right next step.
What you get on the waitlist
- Beta access to the platform as features ship.
- First access to evidence asset offerings.
- A short intro call with the team.
- Updates on the MEDopathies proof-of-concept.
Need a conversation first
Have procurement, compliance, or technical questions before joining the waitlist?